Employer-focused pharmacy advantages corporate Truveris raises $15M
Truveris, a condition era corporate interested in lowering prescription prices for employers and their participants, introduced it connect $15 million in Layout E funding.
Current buyers Canaan Companions and Unused Leaf Challenge Companions led the spherical.
WHAT IT DOES
The corporate supplies era to backup employers conserve decrease drug pricing plans. Its instrument additionally lets in sponsors to garner data-driven insights to release prescription prices, toughen pharmacy receive advantages supervisor word phrases and build up recovery get admission to.
The budget will probably be old to assistance the corporate’s operational enlargement.
“There has never been more attention placed on PBM practices and the impact on pharmacy costs as there is right now. For years, Truveris has been at the forefront of developing technology to address the most pressing challenges in PBM management and cost containment. We are pleased to increase our investment in Truveris and extend our partnership to support the next chapter in the Company’s evolution,” Vijay Lathi, managing director at Unused Leaf Challenge Companions, stated in a commentary.
MARKET SNAPSHOT
The prescription advantages corporate garnered $25 million in Layout D investment in 2017.
Previous this week, the corporate introduced it used to be selling Garrett Fienberg to eminent running officer, Gregg DiPietro as eminent industrial officer, and Louise Shea as eminent pharmacy officer.
Fienberg in the past served as head of enlargement operations, DiPietro held the placement of eminent advertising officer, and Shea’s closing place within the corporate used to be senior vice chairman of product technique.
Alternative firms interested in lowering prescription prices come with drug price and telehealth platform GoodRx, Waltz Health, Mark Cuban Cost Plus Drug Company, Amazon and Transcarent, a healthcare platform for self-insured employers.
